USA orders are completed as needed when severe cases present, 'Just-in-time' delivery style...So, still very early days in the US for BTM.
I'm glad as well the DFU study is now similarly focused on the serious use case scenarios - I.e. limb salvage.
Much like the 'sustainability' focus in India that Swami talks about. Meeting the highest need patient scenarios may not have the highest TAM (in theory). But the stakeholder engagement & market penetration = long term growth & profit....
I'm punting on a T/O offer at around $200M rev. (run rate) in 18 months time... by this time the above & more will be maturing nicely. Target $5-6 with a lot of volatility along the way.
PNV Price at posting:
$2.14 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)